Earnings summaries and quarterly performance for AVIENT.
Executive leadership at AVIENT.
Ashish K. Khandpur
Detailed
President and Chief Executive Officer
CEO
AM
Amy M. Sanders
Detailed
Senior Vice President, General Counsel, Secretary and Corporate Ethics Officer
CL
Christopher L. Pederson
Detailed
Senior Vice President, President of Specialty Engineered Materials
JA
Jamie A. Beggs
Detailed
Senior Vice President, Chief Financial Officer
Board of directors at AVIENT.
EN
Ernest Nicolas
Detailed
Director
GJ
Gregory J. Goff
Detailed
Director
KJ
Kerry J. Preete
Detailed
Director
KA
Kim Ann Mink
Detailed
Director
NG
Neil Green
Detailed
Director
PV
Patricia Verduin
Detailed
Director
RH
Richard H. Fearon
Detailed
Non-Executive Chairman of the Board
RE
Robert E. Abernathy
Detailed
Director
SB
Sandra Beach Lin
Detailed
Director
WA
William A. Wulfsohn
Detailed
Director
WR
William R. Jellison
Detailed
Director
Research analysts who have asked questions during AVIENT earnings calls.
Kristen Owen
Oppenheimer & Co. Inc.
6 questions for AVNT
Also covers: , AGCO, BHIL +15 more
Michael Sison
Wells Fargo
6 questions for AVNT
Also covers: ALB, APD, ASH +16 more
Frank Mitsch
Fermium Research
5 questions for AVNT
Also covers: CE, CTVA, DD +13 more
Ghansham Panjabi
Robert W. Baird & Co.
3 questions for AVNT
Also covers: AMCR, ATR, AVY +20 more
LA
Laurence Alexander
Jefferies
3 questions for AVNT
Also covers: AIQUY, ALB, APD +27 more
MH
Michael Harrison
Seaport Research Partners
3 questions for AVNT
Also covers: APD, ASH, AXTA +17 more
MH
Mike Harrison
Seaport Research Partners
3 questions for AVNT
Also covers: ASH, AVD, AXTA +16 more
DR
Dan Rosenthal
Jefferies
2 questions for AVNT
Emily Fusco
Deutsche Bank
2 questions for AVNT
Also covers: APD, CBT, CTVA +4 more
TH
Turner Hendricks
Morgan Stanley
2 questions for AVNT
Also covers: CE
Vincent Andrews
Morgan Stanley
2 questions for AVNT
Also covers: ALB, APD, AXTA +20 more
YH
YIfei Huang
Deutsche Bank
2 questions for AVNT
Also covers: RPM
AY
Aleksey Yefremov
KeyBanc Capital Markets
1 question for AVNT
Also covers: ALB, ALTM, AXTA +17 more
Aziza Gazieva
Fermium Research
1 question for AVNT
Also covers: CE, PPG, TROX +1 more
DB
David Begleiter
Deutsche Bank
1 question for AVNT
Also covers: ALB, APD, ASH +24 more
GP
Gansham Panjamy
Robert W. Baird
1 question for AVNT
Kevin Estok
Jefferies
1 question for AVNT
Also covers: ASH, CBT, CE +8 more
R
Ryan
B. Riley
1 question for AVNT
Also covers: ARLO, AXTA, BEEM +4 more
SH
Steven Haynes
Morgan Stanley
1 question for AVNT
Also covers: ADM, APD, ASH +3 more
TH
Turner Hinrichs
Morgan Stanley
1 question for AVNT
Also covers: DD, EMN, HUN +1 more
Recent press releases and 8-K filings for AVNT.
Avient Reports Strong Q4 and Full-Year 2025 Results, Provides 2026 Guidance
AVNT
Earnings
Guidance Update
New Projects/Investments
- Avient reported 80 basis points of Adjusted EBITDA margin expansion and 14% Adjusted EPS growth for Q4 2025, with organic sales slightly down 0.8% and reported sales up 1.9%.
- For the full year 2025, the company achieved record high Adjusted EBITDA margins of 16.7% and $545 million in Adjusted EBITDA, with Adjusted EPS growing 6%.
- Avient generated $195 million of free cash flow in 2025, enabling a $150 million reduction in outstanding debt and ending the year with a net leverage ratio of 2.6x.
- The company provided full-year 2026 guidance, projecting Adjusted EBITDA between $555 million and $585 million and Adjusted EPS between $2.93 and $3.17.
- Strategic initiatives include innovation in non-PFAS products and expanding Dyneema fiber making capacity to support growth in defense, healthcare, and telecom markets.
Feb 12, 2026, 1:00 PM
Avient Reports Q4 and Full-Year 2025 Results, Provides 2026 Financial Guidance
AVNT
Earnings
Guidance Update
New Projects/Investments
- Avient reported Q4 2025 Adjusted EPS of $0.56 and full-year 2025 Adjusted EPS of $2.82, representing 14.3% and 6.0% year-over-year growth, respectively.
- For Q4 2025, sales were $761 million and Adjusted EBITDA was $118 million, with an Adjusted EBITDA margin of 15.5%, an 80 basis point expansion.
- Full-year 2025 sales reached $3,260 million and Adjusted EBITDA was $545 million, achieving an Adjusted EBITDA margin of 16.7%, a 50 basis point expansion.
- The company strengthened its balance sheet by paying down $150 million in debt, reducing net leverage to 2.6x as of December 31, 2025.
- Avient provided 2026 financial guidance, projecting full-year Adjusted EBITDA between $555 million and $585 million and Adjusted EPS between $2.93 and $3.17, alongside Q1 2026 Adjusted EPS guidance of $0.81.
Feb 12, 2026, 1:00 PM
Avient Reports Q4 and Full-Year 2025 Results, Provides 2026 Guidance
AVNT
Earnings
Guidance Update
New Projects/Investments
- Avient reported full-year 2025 Adjusted EBITDA of $545 million and Adjusted EPS growth of 6%, achieving record high Adjusted EBITDA margins of 16.7%. The company generated $195 million in free cash flow, reducing outstanding debt by $150 million and ending the year with a net leverage ratio of 2.6x.
- For Q4 2025, the company saw 14% Adjusted EPS growth and 80 basis points of Adjusted EBITDA margin expansion, with organic sales down slightly by 0.8%. Strong momentum continued in defense, healthcare, and telecom markets, which grew double digits.
- Avient issued full-year 2026 guidance for Adjusted EBITDA between $555 million and $585 million (up 2%-7% year-over-year) and Adjusted EPS between $2.93 and $3.17 (up 4%-12% over prior year).
- The company expects $200 million-$220 million in free cash flow for 2026, with planned capital expenditures of $140 million to support growth, particularly in the defense business. The strategic focus for 2026 is on continued organic growth and innovation, with no M&A expected, prioritizing further debt reduction to below 2.5x net leverage.
Feb 12, 2026, 1:00 PM
Avient Reports Strong Q4 and Full-Year 2025 Results, Provides 2026 Guidance
AVNT
Earnings
Guidance Update
New Projects/Investments
- Avient reported strong Q4 2025 performance with 80 basis points of Adjusted EBITDA margin expansion and 14% Adjusted EPS growth, despite organic sales being down 0.8%.
- For the full year 2025, the company achieved record high Adjusted EBITDA margins of 16.7% (up 50 basis points year-over-year), with Adjusted EBITDA at $545 million and Adjusted EPS growth of 6%.
- Avient generated $195 million in free cash flow in 2025, enabling a $150 million debt reduction and lowering net leverage to 2.6x from 3.1x in 2023.
- The company provided 2026 guidance, projecting Adjusted EBITDA between $555 million and $585 million (up 2%-7%) and Adjusted EPS between $2.93 and $3.17 (up 4%-12%), with anticipated free cash flow of $200 million to $220 million.
- Strategic focus on innovation led to new product launches like GlideTech technology, and growth vectors (defense, healthcare, telecom) grew high single digits in 2025, significantly outpacing other businesses.
Feb 12, 2026, 1:00 PM
Avient Announces Fourth-Quarter and Full-Year 2025 Results, Initiates 2026 Guidance
AVNT
Earnings
Guidance Update
- Avient reported fourth quarter 2025 sales of $761 million and full-year 2025 sales of $3,260 million, representing increases of 2% and 1% respectively.
- Adjusted EPS for Q4 2025 grew 14% to $0.56, contributing to a full-year 2025 adjusted EPS of $2.82.
- The company generated $302 million in operating cash flow for full-year 2025 and repaid $150 million in debt.
- For full-year 2026, adjusted EPS is projected to be between $2.93 and $3.17, indicating 4% to 12% growth over 2025, with Q1 2026 adjusted EPS expected at $0.81.
- Full-year 2026 adjusted EBITDA is forecast at $555 to $585 million, and free cash flow is anticipated to exceed $200 million.
Feb 12, 2026, 11:17 AM
Avient Announces Q4 and Full-Year 2025 Results, Provides 2026 Guidance
AVNT
Earnings
Guidance Update
- Avient reported Q4 2025 sales of $761 million, an increase of 2%, and full-year 2025 sales of $3,260 million, up 1%.
- Full-year 2025 adjusted EPS increased 6% to $2.82, while Q4 2025 adjusted EPS grew 14% to $0.56.
- The company generated $302 million in operating cash flow for full-year 2025 and repaid $150 million in debt.
- For full-year 2026, adjusted EPS is expected to range from $2.93 to $3.17, and adjusted EBITDA from $555 million to $585 million.
- Avient projects Q1 2026 adjusted EPS to be $0.81, reflecting 7% growth over the prior year quarter.
Feb 12, 2026, 11:01 AM
AVNT Reports Q3 2025 Adjusted EPS of $0.70 Amidst Mixed Market Conditions
AVNT
Earnings
Guidance Update
Demand Weakening
- AVNT reported adjusted EPS of $0.70 for Q3 2025, representing 7.7% year-over-year growth as reported, and expanded adjusted EBITDA margins by 60 basis points to 16.5%.
- The company experienced subdued demand in consumer and packaging markets, with consumer sales down high single digits globally, but saw resilience and high single-digit growth in defense, healthcare, and telecommunications segments.
- For Q4, AVNT anticipates slightly better year-over-year sales performance than Q3, driven by continued strength in resilient markets, and is on track to achieve approximately $40 million in productivity benefits for 2025.
- AVNT plans to pay down $50 million in debt in Q4 and aims to reach a net debt to EBITDA ratio of 2.5 times by the second half of 2026, at which point share repurchases would be considered.
Nov 5, 2025, 1:00 PM
Avient Reports Q3 2025 Results and Updates Full-Year Guidance
AVNT
Earnings
Guidance Update
Demand Weakening
- Avient Corporation reported Q3 2025 sales of $807 million, Adjusted EBITDA of $133 million, and Adjusted EPS of $0.70, reflecting 7.7% growth as reported.
- For the September YTD 2025 period, the company achieved sales of $2,500 million, Adjusted EBITDA of $427 million, and Adjusted EPS of $2.26.
- The company expanded Adjusted EBITDA margins by 60 basis points in Q3 2025, driven by favorable mix and productivity initiatives, contributing to the growth in EPS despite weaker sales.
- Avient updated its full-year 2025 Adjusted EBITDA guidance to $540 million to $550 million (a reduction from prior guidance of $545 million to $560 million), while reaffirming its Adjusted EPS guidance at $2.77 to $2.87.
- Growth in defense, healthcare, and telecom sales was offset by subdued demand in consumer, packaging, industrial, and energy markets, and the company paid down $100 million in debt during the period.
Nov 5, 2025, 1:00 PM
Avient Announces Third Quarter 2025 Results
AVNT
Earnings
Guidance Update
Demand Weakening
- Avient reported third quarter 2025 sales of $806.5 million, a 1% decrease from the prior year quarter, which included a 2% favorable impact from foreign exchange.
- GAAP EPS for Q3 2025 was $0.36, compared to $0.41 in the prior year quarter, while adjusted EPS grew 8% to $0.70.
- The company maintained its full-year 2025 adjusted EPS guidance range of $2.77 to $2.87, reflecting 4% to 8% year-over-year growth.
- Avient updated its full-year 2025 adjusted EBITDA guidance to $540 to $550 million and expects to repay a total of $150 million in debt for the full year 2025.
- Despite weaker-than-expected sales due to weak consumer sentiment, evolving trade policy, and geopolitical uncertainty, the company achieved adjusted EBITDA margin expansion of 60 basis points to 16.5% in Q3 2025.
Nov 5, 2025, 11:15 AM
Avient Corporation Announces Third Quarter 2025 Results
AVNT
Earnings
Guidance Update
- Avient Corporation reported third quarter 2025 sales of $806.5 million, a 1% decrease compared to the prior year quarter.
- GAAP EPS for Q3 2025 was $0.36, while adjusted EPS grew 8% to $0.70, aligning with prior guidance.
- The company maintained its full-year 2025 adjusted EPS guidance range of $2.77 to $2.87 and updated its full-year adjusted EBITDA guidance to $540 to $550 million.
- Adjusted EBITDA margins expanded by 60 basis points to 16.5% in the third quarter.
- Avient repaid $100 million of debt year-to-date and expects total debt repayment of $150 million for the full year 2025.
Nov 5, 2025, 11:01 AM
Quarterly earnings call transcripts for AVIENT.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more